Clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus - Scientific guideline
This document provides guidance on clinical development programmes intended to support the registration of new medicinal products for the treatment of diabetes mellitus. It also addresses the development of products to delay in onset or prevention of diabetes mellitus or preservation of beta-cell function in patients with diabetes.
Keywords: Diabetes, drug evaluation, clinical development, treatment, prevention, glucose-lowering agents, insulin, confirmatory studies.
-
List item
Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus - Revision 2 (PDF/405.33 KB)
Adopted
First published: 28/06/2023
Legal effective date: 01/01/2024
CPMP/EWP/1080/00 Rev.2 -
List item
Overview of comments received on the draft guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus - Revision 2 (PDF/1008.15 KB)
First published: 28/06/2023
EMA/279883/2023 -
List item
Reflection paper on data required in confirmatory studies of medicinal products for the treatment of type 2 diabetes - Revision 2 (PDF/194.38 KB)
Draft: consultation closed
First published: 20/05/2022
Consultation dates: 20/05/2022 to 31/08/2022
EMA/240473/2022 -
List item
Draft guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus - Revision 2 (PDF/263.59 KB)
Draft: consultation closed
First published: 07/02/2018
Last updated: 07/02/2018
Consultation dates: 07/02/2018 to 15/08/2018
CPMP/EWP/1080/00 Rev. 2 -
List item
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus (PDF/92.69 KB)
Draft: consultation closed
First published: 28/07/2016
Last updated: 07/02/2018
Consultation dates: 28/07/2016 to 31/10/2016
EMA/317855/2016
-
List item
Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus - Revision 1 (PDF/224.98 KB)
Adopted
First published: 29/06/2012
Last updated: 29/06/2012
CPMP/EWP/1080/00 -
List item
Overview of comments received on the guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus (CPMP/EWP/1080/00 Rev. 1) (PDF/516.12 KB)
First published: 31/07/2012
Last updated: 31/07/2012
EMA/444348/2012 -
List item
Draft guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus (second and final release for public consultation) - Revision 1 (second release) (PDF/198.93 KB)
Draft: consultation closed
First published: 07/10/2011
Last updated: 07/10/2011
Consultation dates: 16/09/2011 to 18/11/2011
CPMP/EWP/1080/00 Rev. 1* -
List item
Draft guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus - Revision 1 (PDF/254.85 KB)
Draft: consultation closed
First published: 10/02/2010
Last updated: 10/02/2010
Consultation dates: 20/01/2010 to 31/07/2010
CPMP/EWP/1080/00 -
List item
Concept paper on the need for revision of the note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus - Revision 1 (PDF/44.26 KB)
First published: 30/05/2008
EMEA/CHMP/EWP/176348/2008